AusCann Group Holdings Ltd (ASX: AC8) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Auscann Group Holdings Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $18.06 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 440.55 million
Earnings per share -0.023
Dividend per share N/A
Year To Date Return -45.68%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

AusCann Group Holdings Ltd (ASX: AC8)
Latest News

little green pharma share price represented by cannabis leaf character jumping cheerfully
Cannabis Shares

Blazing it? How the top ASX cannabis shares performed in FY21

How did ASX cannabis shares fare in FY21?

Read more »

various forms of medicinal cannabis
Cannabis Shares

CBD to be sold in pharmacies, ASX cannabis shares react

Last week, it became legal to sell cannabidiol (CBD) products in chemists and pharmacies. We take a look at the…

Read more »

asx share price represented by green cannabis leaf sitting atop red maple leaves
Share Market News

Why the AusCann (ASX:AC8) share price jumped 14% higher today

The AusCann Group Holdings Ltd (ASX:AC8) share price is on the move on Friday after announcing the appointment of its…

Read more »

medical marijuana, cannabis, pot, drug, medical
Best Shares

5 top ASX cannabis shares in 2020

We take a closer look at the 5 top ASX cannabis shares in 2020 and how they delivered for shareholders…

Read more »

marijuana leaf with upward facing arrow
Share Gainers

ASX pot stocks have been skyrocketing in December

Recent global events have caused the share prices of many ASX pot stocks to skyrocket. Let's take a closer look.

Read more »

Galaxy Resources capital raisegrowth in asx share price represented by multiple hands all placing coins in a piggy bank
Share Market News

Elixinol (ASX:EXL) share price tumbles on capital raising update

The Elixinol Global Ltd (ASX: EXL) share price tumbled after management issued an update to its share purchase plan (SPP)…

Read more »

asx cannabis shares represented by pug dog pointing to blackboard with cannabis info on it
Share Market News

ASX stock of the day: CannPal Animal Therapeutics (ASX:CP1) shares shoot 25%

The CannPal Animal Therapeutics Ltd (ASX: CP1) share price is shooting the moon today. Here's why this ASX cannabis company…

Read more »

A man with binoculars crouched in the bush, indication a share price on watch
Share Market News

Look out for the Auscann (ASX:AC8) and Cannpal (ASX:CP1) share prices post trading halt

Auscann Group Holdings and Cannpal Animal Therapeutics should emerge from their trading halt tomorrow. Here's why to watch...

Read more »

AC8 ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About AusCann Group Holdings Ltd

Auscann Group Holdings Ltd (ASX: AC8) is a pharmaceutical company based in Western Australia. Its focus is on developing, producing and distributing a range of cannabinoid treatments for use in Australia and internationally.

According to Auscann, the company’s products are the result of a stringent development program that aims to produce stable and effective cannabinoid-based medicines. Auscann also seeks to generate clinical evidence supporting the efficacy of its products to support further market penetration.

Whilst working directly with patients, Auscann’s primary focus is on providing healthcare professionals with optimal treatment solutions to help them better care for their patients. The company also provides healthcare professionals with the tools to personalise and adjust dosage and treatment programs for each individual.

AusCann was readmitted to the ASX in early 2017 after it was acquired by the already listed company TW Holdings Limited. In the months following, the Auscann share price surged by nearly 200%. Within 12 months, the Auscann share price had gone on to deliver growth of nearly 500% over its ASX readmittance value. Since then however, the Auscann share price has trended lower and has not traded over $1 since late 2018.

AC8 Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
08 Aug 2022 $0.04 $0.00 0.00% 75,980 $0.04 $0.05 $0.04
05 Aug 2022 $0.04 $0.00 0.00% 155,843 $0.04 $0.05 $0.04
04 Aug 2022 $0.04 $0.00 0.00% 130,939 $0.04 $0.05 $0.04
03 Aug 2022 $0.04 $0.00 0.00% 17,655 $0.05 $0.05 $0.04
02 Aug 2022 $0.04 $0.00 0.00% 60,272 $0.04 $0.04 $0.04
01 Aug 2022 $0.04 $0.00 0.00% 876,876 $0.04 $0.05 $0.04
29 Jul 2022 $0.05 $0.00 0.00% 52,900 $0.05 $0.05 $0.05
28 Jul 2022 $0.05 $0.00 0.00% 205,910 $0.05 $0.05 $0.05
27 Jul 2022 $0.05 $0.00 0.00% 49,319 $0.05 $0.05 $0.05
26 Jul 2022 $0.05 $0.00 0.00% 101,976 $0.05 $0.05 $0.05
25 Jul 2022 $0.05 $0.00 0.00% 43,995 $0.05 $0.05 $0.05
22 Jul 2022 $0.05 $0.00 0.00% 107,079 $0.05 $0.05 $0.05
21 Jul 2022 $0.05 $0.00 0.00% 135,702 $0.05 $0.05 $0.05
20 Jul 2022 $0.05 $0.00 0.00% 128,962 $0.05 $0.05 $0.05
19 Jul 2022 $0.05 $0.00 0.00% 174,718 $0.05 $0.05 $0.05
18 Jul 2022 $0.05 $0.00 0.00% 46,397 $0.04 $0.05 $0.04
15 Jul 2022 $0.05 $0.00 0.00% 387,167 $0.05 $0.05 $0.05
14 Jul 2022 $0.05 $0.00 0.00% 198,179 $0.05 $0.05 $0.05
13 Jul 2022 $0.05 $0.00 0.00% 526,101 $0.04 $0.05 $0.04
12 Jul 2022 $0.04 $0.00 0.00% 283,647 $0.04 $0.04 $0.04

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
04 Nov 2021 Krista Bates Transfer 427 $44,000
Off-market transfer.
04 Nov 2021 Krista Bates Transfer 427 $44,000
Off-market transfer.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Ms Krista Bates Non-Executive Director Dec 2019
Ms Bates has 21 years of expertise in the legal market. She was a Partner at leading Western Australian law firm Lavan specialising in Corporate law and was
Head of Mining & Resources and the Medical Cannabis Group.
Mr Robert Clifford Non-Executive Director Apr 2021
Mr Clifford has more than 25 years of experience in Food and beverage industry. Mr Clifford has held various executive management positions in Perth, Canberra and Macau.
Mr Christopher (Chris) Lee Mews Non-Executive Director Dec 2019
Mr Mews is an experienced non-executive director with over 20 years in the financial services sector, having held senior positions in finance, corporate secretarial and compliance in listed and unlisted companies.
Mr Tod Stephen McGrouther Non-Executive ChairmanNon-Executive Director Dec 2021
Mr McGrouther has over 35 years of experience in the Australian capital markets primarily in the areas of equity capital markets and corporate advisory. Between 1986 and 1994 he was an Associate Director of Bankers Trust Australia Limited where he was involved in a number merger and acquisition advisory and float advisory assignments including the float of the Commonwealth Bank and the float of Woolworths. Between 1994 and 1998 he was a Director of Prudential Bache Securities Australia Limited where he was involved in a number of initial public offerings. From 1998 until the present Mr McGrouther is a principal of equity capital markets firm KTM Capital. Since 2018 Mr McGrouther has been a Director of European Cannabis Corporation Limited ("ECC"). Mr McGrouther is currently a Non-Executive Director of three ASX listed companies - NSX Limited, Urbanise Limited and Love Group Limited. Mr McGrouther is also Chairman of The National Stock Exchange of Australia Limited a subsidiary of NSX Limited.
Mr Layton Patrick Mills Chief Executive Officer Mar 2021
Ms Susan Patricia Park Company Secretary Oct 2016
Mr Quentin Heath Megson Chief Financial OfficerJoint Company Secretary Feb 2019
Layton Patrick Mills Chief Executive Officer
Quentin Heath Megson Chief Financial OfficerJoint Company Secretary
Susan Patricia Park Company Secretary

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
The Trust Company (Australia) Limited (MOF A/C) 56,379,750 12.80%
Citicorp Nominees Pty Limited 12,263,518 2.78%
Mr Layton Patrick Mills (DJs Family A/C) 11,387,582 2.58%
Ms Tania Maree Vidovic (Star V Family A/C) 7,400,874 1.68%
Merrill Lynch (Australia) Nominees Pty Limited 5,754,883 1.31%
Mr George Chien Hsun Lu & Mrs Jenny Chin Pao Lu 4,958,999 1.13%
Pepaanne Pty Ltd (The Chapman Family A/C) 4,600,000 1.04%
Mr Warren Sidney Langman 4,235,928 0.96%
HSBC Custody Nominees (Australia) Limited 3,340,101 0.76%
Bnp Paribas Nominees Pty Ltd (Ib Au Noms Retailclient Drp) 2,813,910 0.64%
Bnp Paribas Nominees Pty Ltd Acf Clearstream 2,639,184 0.60%
Ajava Holdings Pty Ltd 2,600,000 0.59%
Miss Xiaodan Fu 2,577,402 0.59%
Mr George Chien-Hsun Lu 2,569,999 0.58%
Bnp Paribas Noms Pty Ltd (DRP) 2,563,129 0.58%
Marcus Kelly Property Developments Pty Ltd 2,500,000 0.57%
Wil & Jack Pty Ltd (Wil & Jack Family A/C) 2,348,106 0.53%
Lus International Limited 2,339,999 0.53%
Mr John Andrew Rodgers (John Rodgers Family A/C) 2,316,372 0.53%
Ms Kate Eloise Toft (Johnstone Family A/C) 2,237,521 0.51%